Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia

NCT00445900 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloproliferative Disorders
Secondary Myelofibrosis

Interventions

DRUG: cyclophosphamide
DRUG: prednisone
DRUG: thalidomide
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis
PROCEDURE: biopsy

Sponsor

Mayo Clinic

Collaborators

[object Object]